BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 15183948)

  • 1. Application of TNM, 2002 version, in localized renal cell carcinoma: is it able to predict different cancer-specific survival probability?
    Ficarra V; Novara G; Galfano A; Novella G; Schiavone D; Artibani W
    Urology; 2004 Jun; 63(6):1050-4. PubMed ID: 15183948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma.
    Ficarra V; Schips L; Guillè F; Li G; De La Taille A; Prayer Galetti T; Cindolo L; Novara G; Zigeuner RE; Bratti E; Tostain J; Altieri V; Abbou CC; Artibani W; Patard JJ
    Cancer; 2005 Sep; 104(5):968-74. PubMed ID: 16007683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reassessment of the 1997 TNM classification system for renal cell carcinoma.
    Elmore JM; Kadesky KT; Koeneman KS; Sagalowsky AI
    Cancer; 2003 Dec; 98(11):2329-34. PubMed ID: 14635066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pT1 substaging in renal cell carcinoma: validation of the 2002 TNM staging modification of malignant renal epithelial tumors.
    Salama ME; Guru K; Stricker H; Peterson E; Peabody J; Menon M; Amin MB; De Peralta-Venturina M
    J Urol; 2005 May; 173(5):1492-5. PubMed ID: 15821466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
    Becker F; Siemer S; Humke U; Hack M; Ziegler M; Stöckle M
    Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors of papillary renal cell carcinoma: results from a multi-institutional series after pathological review.
    Herrmann E; Trojan L; Becker F; Wülfing C; Schrader AJ; Barth P; Stöckle M; Hammerschmied CG; Staehler M; Stief C; Haferkamp A; Hohenfellner M; Legal W; Wullich B; Bolenz C; Klein T; Noldus J; Bierer S; Hertle L; Brenner W; Roos F; Michel MS; Walter B; Wieland W; Gerss J; Otto W; Hartmann A
    J Urol; 2010 Feb; 183(2):460-6. PubMed ID: 20006851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposal for revision of the TNM classification system for renal cell carcinoma.
    Ficarra V; Guillè F; Schips L; de la Taille A; Prayer Galetti T; Tostain J; Cindolo L; Novara G; Zigeuner R; Bratti E; Li G; Altieri V; Abbou CC; Zanolla L; Artibani W; Patard JJ
    Cancer; 2005 Nov; 104(10):2116-23. PubMed ID: 16208703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-size breakpoint for prognostic stratification of localized renal cell carcinoma.
    Ficarra V; Prayer-Galetti T; Novara G; Bratti E; Zanolla L; Dal Bianco M; Artibani W; Pagano F
    Urology; 2004 Feb; 63(2):235-9; discussion 239-40. PubMed ID: 14972460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
    Haferkamp A; Kurosch M; Pritsch M; Hatiboglu G; Macher-Goeppinger S; Pfitzenmaier J; Pahernik S; Wagener N; Hohenfellner M
    Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does renal capsular invasion have any prognostic value in localized renal cell carcinoma?
    Süer E; Ergün G; Baltaci S; Bedük Y
    J Urol; 2008 Jul; 180(1):68-71. PubMed ID: 18485385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposal for reclassification of the TNM staging system in patients with locally advanced (pT3-4) renal cell carcinoma according to the cancer-related outcome.
    Ficarra V; Novara G; Iafrate M; Cappellaro L; Bratti E; Zattoni F; Artibani W
    Eur Urol; 2007 Mar; 51(3):722-9; discussion 729-31. PubMed ID: 16904819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort.
    Frank I; Blute ML; Leibovich BC; Cheville JC; Lohse CM; Zincke H
    J Urol; 2005 Jun; 173(6):1889-92. PubMed ID: 15879769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
    Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
    BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.
    Komai Y; Saito K; Sakai K; Morimoto S
    BJU Int; 2007 Jan; 99(1):77-80. PubMed ID: 16956357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
    Cindolo L; Patard JJ; Chiodini P; Schips L; Ficarra V; Tostain J; de La Taille A; Altieri V; Lobel B; Zigeuner RE; Artibani W; Guillé F; Abbou CC; Salzano L; Gallo C
    Cancer; 2005 Oct; 104(7):1362-71. PubMed ID: 16116599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
    Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
    J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival.
    Carini M; Minervini A; Lapini A; Masieri L; Serni S
    J Urol; 2006 Jun; 175(6):2022-6; discussion 2026. PubMed ID: 16697790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
    Pahernik S; Cudovic D; Roos F; Melchior SW; Thüroff JW
    BJU Int; 2007 Jul; 100(1):26-9. PubMed ID: 17552949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.